Corcept Therapeutics revenue

Corcept Therapeutics revenue decreased from $N/A in 2017 to $N/A in 2018, a NaN% decrease.

Annual Revenue ($)

Corcept Therapeutics revenue was $81.32 m in FY, 2016 which is a 61.7% year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2013FY, 2014FY, 2015FY, 2016
Revenue$10.36 m$26.55 m$50.29 m$81.32 m
Growth156.36%89.39%61.72%
Q3, 2013Q3, 2014
Revenue$2.63 m$7.28 m

Annual Growth Rate (%)